REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ocumension Therapeutics (Hong Kong) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ocumension Therapeutics Profile Updated: November 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Ocumension Therapeutics is a Chinese ophthalmology pharmaceutical platform company focused on building an ophthalmology medicine platform that integrates the full-cycle professional capabilities of eye medicine development from research and development, manufacturing to commercialization. The company was founded in 2018, and headquartered in Shanghai City, China.

Headquarters
502-1 Want Want Plaza, 211 Shimen Yi Road, Jing'An District, Prc
Shanghai; Shanghai;

Contact Details: Purchase the Ocumension Therapeutics (Hong Kong) report to view the information.

Website: http://www.ocumension.com

Basic Information
Total Employees:
Purchase the Ocumension Therapeutics (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Ocumension Therapeutics (Hong Kong) report to view the information.
Registered Capital:
Purchase the Ocumension Therapeutics (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Ocumension Therapeutics (Hong Kong) report to view the information.
Incorporation Date:
2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.99%
Purchase this report to view the information.
14%
Purchase this report to view the information.
12.39%
Purchase this report to view the information.
8.58%
Purchase this report to view the information.
7.46%
Subsidiaries
Ocumension Hong Kong (Hong Kong SAR, China)
100%
Alimera Sciences Inc. (United States)
16.4%
Company Performance
Financial values in the chart are available after Ocumension Therapeutics (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
61.65%▲
Total operating revenue
60.17%▲
Operating profit (EBIT)
26.78%▲
EBITDA
34.5%▲
Net Profit (Loss) for the Period
27.38%▲
Total assets
0.84%▲
Total equity
0.83%▲
Operating Profit Margin (ROS)
118.06%▲
Net Profit Margin
110.68%▲
Return on Equity (ROE)
2.12%▲
Debt to Equity Ratio
-0.34%▼
Quick Ratio
-0.35%▼
Cash Ratio
-0.54%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo